• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchReNeuron
    Picture of ReNeuron logo

    RENE — ReNeuron Share News

    3.38p0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
      £0.53m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • RENE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    RENE Dividends
    • Holding(s) in Company

      12/12/2022 14:31
    • Positive iPSC data presented at conference

      08/12/2022 07:06
    • Second Price Monitoring Extn

      02/12/2022 16:40
    • Price Monitoring Extension

      02/12/2022 16:35
    • Price Monitoring Extension

      02/12/2022 14:00
    • UK-based ReNeuron plunges as co flags funding issues

      02/12/2022 12:29
    • Brief: Reneuron Group Posts HY Loss Of £3.2 Mln

      02/12/2022 07:21
    • Interim Results

      02/12/2022 07:00
    • Positive Exosome data presented at US conference

      07/10/2022 07:00
    • ReNeuron to present new data at Exosome conference

      22/09/2022 07:00
    • Brief: ReNeuron Group Appoints John Hawkins As CFO

      14/09/2022 07:23
    • Directorate and Executive Changes

      14/09/2022 07:00
    • Result of AGM

      09/09/2022 10:58
    • Brief: ReNeuron Group Says Chairman Iain Ross Purchased 100,000 Of Co's Shares Of 1P Each

      02/09/2022 11:02
    • Director/PDMR Shareholding

      02/09/2022 11:01
    • Block Listing Review and Total Voting Rights

      01/09/2022 07:00
    • Posting of AR & Accounts & Notice of AGM

      15/08/2022 15:25
    • Brief: Reneuron Group Appoints Catherine Isted, Acma, As CEO

      01/08/2022 07:14
    • Directorate Change

      01/08/2022 07:00
    • Grant of Options

      15/07/2022 07:00
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.